05/18/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/18/2020. This eight-page form is to be completed for all children aged 0–19 suspected to have multisystem inflammatory disorder temporally related to COVID-19 (even if all criteria in the case definition are not met – to capture full spectrum of the condition). (PDF)
05/15/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/15/2020. The purpose of this eight-page document is to provide guidance on the cleaning and disinfection of environmental surfaces in the context of COVID-19. Environmental surfaces are more likely to be contaminated with the COVID-19 virus in healthcare settings where certain medical procedures are performed. This advice also applies to alternative settings for isolation of persons with COVID-19 experiencing uncomplicated and mild illness, including households and non-traditional facilities. (PDF)
05/15/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 5/15/2020. This 54-minute webinar reviews the strategies and guidance available to help communities stand up rapid COVID-19 testing in a safe and effective way. Speakers discuss a rapid testing center, drive-up testing site, and drive-through testing site. (Video or Multimedia)
05/15/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/15/2020. This scientific brief provides a preliminary case definition for multisystem inflammatory disorder in children and adolescents temporally related to COVID-19. The preliminary case definition reflects the clinical and laboratory features observed in children reported to date, and serves to identify suspected or confirmed cases both for the purpose of providing treatment and for provisional reporting and surveillance. The case definition will be revised as more data become available. (Text)
05/15/2020 12:00 AM EDT
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 5/15/2020. This 50-page report summarizes key findings of a selection of published pediatric literature related to COVID-19 mitigation strategies for schools, and provides recommendations for areas where additional study and expedited research are needed. Recognizing that many countries are opening schools now, it summarizes the approaches and plans of several countries in their efforts to resume in-classroom education, as it will be important to observe whether and how these measures ultimately affect disease transmission. (PDF)
05/15/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/15/2020. This three-page document describes reports from Europe and North America about clusters of children and adolescents requiring admission to intensive care units with a multisystem inflammatory condition with some features similar to those of Kawasaki disease and toxic shock syndrome, and which may be related to COVID-19. It provides a preliminary case definition and case report form for multisystem inflammatory disorder in children and adolescents. (PDF)
05/14/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/14/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Aptima® SARS-CoV-2 assay, which received an Emergency Use Authorization from the Food and Drug Administration on May 14, 2020. The Aptima® SARS-CoV-2 assay is authorized for use on respiratory specimens collected from individuals meeting COVID-19 clinical and/or epidemiological criteria. (PDF)
05/14/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/14/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the NeoPlex™ COVID-19 Detection Kit, which received an Emergency Use Authorization from the Food and Drug Administration on May 14, 2020. The NeoPlex™ COVID-19 Detection Kit is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
05/14/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/14/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the G Medical VSMS ECG Patch. The VSMS Patch is authorized for emergency use in the hospital setting for remote monitoring of the QT interval of an electrocardiogram (ECG) in general care (i.e., not in the intensive care unit) patients who are 18 years of age or older and are undergoing treatment for COVID-19 using drugs that can prolong the QT intervals and may cause life-threatening arrhythmias ( e.g., hydroxychloroquine or chloroquine, especially when used in combination with azithromycin). (PDF)
05/13/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/13/2020. The purpose of this 11-page document, updated on May 13, 2020, is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients that meet the case definition of COVID-19. (PDF)
05/10/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/10/2020. This guidance, updated on May 10, 2020, is intended to provide key actions that local and state health departments, homelessness service systems, housing authorities, emergency planners, healthcare facilities, and homeless outreach services can take to protect people experiencing homelessness from the spread of COVID-19 (coronavirus). (Text)
05/10/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/10/2020. This six-page document provides considerations for decision-makers and educators on how or when to reopen or close schools in the context of COVID-19. These decisions have important implications for children, parents or caregivers, teachers, and other staff, communities, and society at large. (PDF)
05/08/2020 12:00 AM EDT
Source: American Society for Healthcare Engineering (ASHE). Published: 5/8/2020. This web page provides information and links for a webinar series to assist healthcare facility managers in planning for and carrying out recovery measures to restore operational capabilities to appropriate post-COVID-19 pandemic levels. (Video or Multimedia)
05/04/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/4/2020. This web page, updated on May 4, 2020, provides specific guidance for the collection and submission of postmortem specimens from deceased known or suspected COVID-19 cases. It also provides recommendations for biosafety and infection control practices during specimen collection and handling, including during autopsy procedures. (Text)
05/01/2020 12:00 AM EDT
Source: Centers for Medicare & Medicaid Services (CMS). Published: 5/2020. This 74-page toolkit catalogs the many innovative solutions designed at the state level to protect the nation’s vulnerable nursing home residents during the coronavirus disease 2019 (COVID-19) pandemic. Major categories within the tables include: State Actions for COVID Management and Response; Telehealth; and Organizations that Are Available to Assist Nursing Homes. (PDF)
05/01/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 5/2020. This 56-page guidance aims to provide a foundation for state, territorial, local, and tribal development of COVID-19 case investigation and contact tracing plans. It is important to note that COVID-19 case investigation and contact tracing activities will vary based on the level of community transmission, characteristics of the community and their populations, and the local capacity to implement case investigation, contact tracing, and COVID-19 testing. (PDF)
05/01/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 5/2020. This nine-page document provides interim guidance to reduce the risk of introducing and transmitting COVID-19 in general population disaster shelters before, during, or after a disaster. It should be used in conjunction with existing shelter operation and management plans, procedures, guidance, resources, and systems, and is not a substitute for shelter planning and preparedness activities. (PDF)
05/01/2020 12:00 AM EDT
Source: George Washington University (GWU). Published: 5/2020. This tool is for state and local leaders to prepare for COVID-19 contact tracing in order to safely reopen and protect the health of communities. It uses a baseline of 15 contact tracers per 100,000 population and increases the number of contact tracers, as needed, to contact trace the 14-day number of new COVID-19 cases for each county over the course of a week. (Text)
04/21/2020 12:00 AM EDT
Source: Rockefeller Foundation. Published: 4/21/2020. This 30-page plan lays out the precise steps necessary to enact robust testing, tracing, and coordination to more safely reopen our economy – starting with a dramatic expansion of testing from one million tests per week to initially three million per week and then 30 million per week, backed by an Emergency Network for COVID-19 Testing to coordinate and underwrite the testing market, a public-private testing technology accelerator, and a national initiative to rapidly expand and optimize the use of U.S., university, and local lab capacity. (PDF)
04/20/2020 12:00 AM EDT
Source: Harvard University. Published: 4/20/2020. This 56-page document is a comprehensive operational roadmap for mobilizing and reopening the U.S. economy in the midst of the COVID-19 crisis. It lays out how a massive scale-up of testing, paired with contact tracing and supported isolation, can rebuild trust in our personal safety and re-mobilize the U.S. economy. (PDF)
04/06/2020 12:00 AM EDT
Source: National Heart, Lung, and Blood Institute [National Institutes of Health] (NHLBI). Published: 4/6/2020. The overarching aim of this application is to understand the impact of the coronavirus pandemic among U.S. men and women with or at risk for HIV infection. We propose to conduct bi-monthly telephone surveys with medical record abstraction for documentation/verification of COVID-19 incidence and clinical outcomes among men and women in the MACS and the WIHS. In order to collect key clinical and psychosocial data on the impact of coronavirus on existing study participants, study staff will attempt to conduct bimonthly remote semi-structured phone interviews with all existing WHIS and MACS participants until the end of the coronavirus pandemic. Ascertainment of key clinical events reported during interview – or via participant-initiated phone contact – will be attempted through collection of medical records. Key clinical events will include: Confirmed diagnosis of coronavirus; Medication prescribed for coronavirus treatment; and participant hospitalization as a result of coronavirus (confirmed) or respiratory distress. Population: Adults only High Risk/Special/Unique Populations Administered by: Trained Lay Examiner/Interviewer Language(s): English, Spanish MACS-WIHS Questionnaire: Full Survey https://www.phenxtoolkit.org/
04/01/2020 12:00 AM EDT
Source: White House. Published: 4/2020. This 20-page document provides guidelines for opening up the country again, with sections on Criteria, Preparedness, and Phased Guidelines. (PDF)
02/20/2020 12:00 AM EST
Source: Naval Postgraduate School, Center for Homeland Security and Defense. Published: 2/20/2020. This 50-minute presentation discusses the COVID-19 outbreak and the status of U.S. preparedness to combat the virus. The speaker explores the broader public health risk environment and identifies additional threats, both natural and man-made, and the changes in U.S. policies and practices necessary to mitigate the risks. (Video or Multimedia)
No hay comentarios:
Publicar un comentario